Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edonerpic in mild to moderate Alzheimer's disease
NCT02079909Phase 2Completed
- Sponsor
- FUJIFILM Toyama Chemical
- Start
- Mar 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edonerpic in Alzheimer's disease (AD), sponsored by FUJIFILM Toyama Chemical. Started Mar 2014; status: completed.
02
Drugs
edonerpic
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02079909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02079909.